Aligos Therapeutics, Inc.AA

Aligos Therapeutics, Inc.

No trades
See on Supercharts

Price target

90.33C0.000.00%
The 3 analysts offering 1 year price forecasts for ALGS have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to ALGS in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
0
Buy
0
Hold
0
Sell
0
Strong sell
0

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ALGS EPS for the last quarter is −2.11 USD despite the estimation of −2.98 USD. In the next quarter EPS is expected to reach −2.36 USD. Track more of Aligos Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Aligos Therapeutics, Inc. revenue is expected to reach ‪433.33 K‬ USD. Check out Aligos Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ALGS price target is 90.33 USD with a max estimate of 175.00 USD and a min estimate of 36.00 USD. Check if this forecast comes true in a year, meanwhile watch Aligos Therapeutics, Inc. stock price chart and keep track of the current situation with ALGS news and stock market news.